Literature DB >> 22266723

Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors.

Kuntal Pal1, Karsten Melcher, H Eric Xu.   

Abstract

Class B G-protein-coupled receptors (GPCRs) are receptors for peptide hormones that include glucagon, parathyroid hormone, and calcitonin. These receptors are involved in a wide spectrum of physiological activities, from metabolic regulation and stress control to development and maintenance of the skeletal system. As such, they are important drug targets for the treatment of diabetes, osteoporosis, and stress related disorders. Class B GPCRs are organized into two modular domains: an extracellular domain (ECD) and a helical bundle that contains seven transmembrane helices (TM domain). The ECD is responsible for the high affinity and specificity of hormone binding, and the TM domain is required for receptor activation and signal coupling to downstream G-proteins. Although the structure of the full-length receptor remains unknown, the ECD structures have been well characterized for a number of Class B GPCRs, revealing a common fold for ligand recognition. This review summarizes the general structural principles that guide hormone binding by Class B ECDs and their implications in the design of peptide hormone analogs for therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266723      PMCID: PMC3690506          DOI: 10.1038/aps.2011.170

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  76 in total

Review 1.  Passing the baton in class B GPCRs: peptide hormone activation via helix induction?

Authors:  Christoph Parthier; Steffen Reedtz-Runge; Rainer Rudolph; Milton T Stubbs
Journal:  Trends Biochem Sci       Date:  2009-05-14       Impact factor: 13.807

2.  Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules.

Authors:  Jonathan A Hern; Asma H Baig; Gregory I Mashanov; Berry Birdsall; John E T Corrie; Sebastian Lazareno; Justin E Molloy; Nigel J M Birdsall
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-20       Impact factor: 11.205

Review 3.  [Gastric inhibitory polypeptide (GIP) receptor].

Authors:  Y Yamada
Journal:  Nihon Rinsho       Date:  1997-10

4.  Monitoring the structural consequences of Phe12-->D-Phe and Leu15-->Aib substitution in human/rat corticotropin releasing hormone. Implications for design of CRH antagonists.

Authors:  Georgios A Spyroulias; Spyridon Papazacharias; George Pairas; Paul Cordopatis
Journal:  Eur J Biochem       Date:  2002-12

5.  Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction.

Authors:  C Bergwitz; T J Gardella; M R Flannery; J T Potts; H M Kronenberg; S R Goldring; H Jüppner
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

6.  Conformational and molecular interaction studies of glucagon-like peptide-2 with its N-terminal extracellular receptor domain.

Authors:  Kalyana C Venneti; Chandralal M Hewage
Journal:  FEBS Lett       Date:  2010-12-15       Impact factor: 4.124

Review 7.  Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes.

Authors:  Michael A Nauck; Birgit Baller; Juris J Meier
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

8.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

9.  Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Ryogo Akasaka; Mitsutoshi Toyama; Takaho Terada; Mikako Shirouzu; Takayuki Shindo; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2008-08-25       Impact factor: 6.725

10.  Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer.

Authors:  Juan José Fung; Xavier Deupi; Leonardo Pardo; Xiao Jie Yao; Gisselle A Velez-Ruiz; Brian T Devree; Roger K Sunahara; Brian K Kobilka
Journal:  EMBO J       Date:  2009-09-17       Impact factor: 11.598

View more
  44 in total

1.  A new era for GPCR research: structures, biology and drug discovery.

Authors:  H Eric Xu; Rui-ping Xiao
Journal:  Acta Pharmacol Sin       Date:  2012-03       Impact factor: 6.150

Review 2.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 3.  Structure of Class B GPCRs: new horizons for drug discovery.

Authors:  Andrea Bortolato; Andrew S Doré; Kaspar Hollenstein; Benjamin G Tehan; Jonathan S Mason; Fiona H Marshall
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

4.  Structure and dynamics of the active human parathyroid hormone receptor-1.

Authors:  Li-Hua Zhao; Shanshan Ma; Ieva Sutkeviciute; Dan-Dan Shen; X Edward Zhou; Parker W de Waal; Chen-Yao Li; Yanyong Kang; Lisa J Clark; Frederic G Jean-Alphonse; Alex D White; Dehua Yang; Antao Dai; Xiaoqing Cai; Jian Chen; Cong Li; Yi Jiang; Tomoyuki Watanabe; Thomas J Gardella; Karsten Melcher; Ming-Wei Wang; Jean-Pierre Vilardaga; H Eric Xu; Yan Zhang
Journal:  Science       Date:  2019-04-12       Impact factor: 47.728

Review 5.  Insights into the structure of class B GPCRs.

Authors:  Kaspar Hollenstein; Chris de Graaf; Andrea Bortolato; Ming-Wei Wang; Fiona H Marshall; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2013-12-18       Impact factor: 14.819

6.  Receptor selectivity from minimal backbone modification of a polypeptide agonist.

Authors:  Shi Liu; Ross W Cheloha; Tomoyuki Watanabe; Thomas J Gardella; Samuel H Gellman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-15       Impact factor: 11.205

7.  Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.

Authors:  Andrea Kirkpatrick; Jiyoung Heo; Ravinder Abrol; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

8.  Genetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class B GPCR.

Authors:  Irene Coin; Vsevolod Katritch; Tingting Sun; Zheng Xiang; Fai Yiu Siu; Michael Beyermann; Raymond C Stevens; Lei Wang
Journal:  Cell       Date:  2013-11-27       Impact factor: 41.582

9.  Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.

Authors:  Maoqing Dong; Polo C-H Lam; Andrew Orry; Patrick M Sexton; Arthur Christopoulos; Ruben Abagyan; Laurence J Miller
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

10.  Structure of the human glucagon class B G-protein-coupled receptor.

Authors:  Fai Yiu Siu; Min He; Chris de Graaf; Gye Won Han; Dehua Yang; Zhiyun Zhang; Caihong Zhou; Qingping Xu; Daniel Wacker; Jeremiah S Joseph; Wei Liu; Jesper Lau; Vadim Cherezov; Vsevolod Katritch; Ming-Wei Wang; Raymond C Stevens
Journal:  Nature       Date:  2013-07-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.